Free Trial

Orion Portfolio Solutions LLC Boosts Holdings in Ingredion Incorporated (NYSE:INGR)

Ingredion logo with Consumer Staples background

Orion Portfolio Solutions LLC grew its position in shares of Ingredion Incorporated (NYSE:INGR - Free Report) by 195.2% in the 3rd quarter, according to the company in its most recent 13F filing with the SEC. The fund owned 11,608 shares of the company's stock after purchasing an additional 7,676 shares during the quarter. Orion Portfolio Solutions LLC's holdings in Ingredion were worth $1,595,000 as of its most recent SEC filing.

Other hedge funds and other institutional investors have also bought and sold shares of the company. Pacer Advisors Inc. lifted its stake in Ingredion by 92.4% during the 2nd quarter. Pacer Advisors Inc. now owns 1,764,012 shares of the company's stock valued at $202,332,000 after acquiring an additional 846,967 shares in the last quarter. Acadian Asset Management LLC raised its stake in shares of Ingredion by 177.8% in the second quarter. Acadian Asset Management LLC now owns 396,743 shares of the company's stock valued at $45,491,000 after buying an additional 253,949 shares during the period. International Assets Investment Management LLC raised its stake in Ingredion by 55,219.9% in the 3rd quarter. International Assets Investment Management LLC now owns 174,811 shares of the company's stock valued at $240,240,000 after acquiring an additional 174,495 shares during the period. Dimensional Fund Advisors LP lifted its holdings in Ingredion by 4.9% during the second quarter. Dimensional Fund Advisors LP now owns 2,685,339 shares of the company's stock valued at $308,009,000 after purchasing an additional 125,543 shares during the last quarter. Finally, Caisse DE Depot ET Placement DU Quebec bought a new position in Ingredion during the third quarter worth about $17,094,000. Institutional investors and hedge funds own 85.27% of the company's stock.

Ingredion Price Performance

NYSE:INGR traded down $0.48 during midday trading on Friday, hitting $144.31. The company had a trading volume of 294,202 shares, compared to its average volume of 391,159. The company has a market capitalization of $9.40 billion, a PE ratio of 14.08, a P/E/G ratio of 1.24 and a beta of 0.74. The company has a quick ratio of 1.69, a current ratio of 2.67 and a debt-to-equity ratio of 0.44. Ingredion Incorporated has a 52-week low of $105.78 and a 52-week high of $155.44. The stock's fifty day moving average price is $141.59 and its 200-day moving average price is $130.51.

Ingredion (NYSE:INGR - Get Free Report) last posted its quarterly earnings data on Tuesday, November 5th. The company reported $3.05 earnings per share (EPS) for the quarter, topping analysts' consensus estimates of $2.58 by $0.47. The firm had revenue of $1.87 billion during the quarter, compared to analysts' expectations of $1.94 billion. Ingredion had a return on equity of 17.75% and a net margin of 9.05%. The company's revenue for the quarter was down 8.0% compared to the same quarter last year. During the same period in the prior year, the business earned $2.33 EPS. As a group, research analysts expect that Ingredion Incorporated will post 10.59 earnings per share for the current year.

Insiders Place Their Bets

In related news, CFO James D. Gray sold 54,869 shares of the firm's stock in a transaction that occurred on Friday, November 29th. The stock was sold at an average price of $146.76, for a total transaction of $8,052,574.44. Following the transaction, the chief financial officer now directly owns 12,795 shares in the company, valued at $1,877,794.20. This trade represents a 81.09 % decrease in their position. The transaction was disclosed in a legal filing with the Securities & Exchange Commission, which is available through the SEC website. Also, CEO James P. Zallie sold 371 shares of the company's stock in a transaction on Thursday, October 10th. The shares were sold at an average price of $133.58, for a total transaction of $49,558.18. Following the sale, the chief executive officer now owns 52,159 shares of the company's stock, valued at $6,967,399.22. This represents a 0.71 % decrease in their ownership of the stock. The disclosure for this sale can be found here. Over the last ninety days, insiders have sold 66,198 shares of company stock valued at $9,702,461. 1.80% of the stock is currently owned by corporate insiders.

Wall Street Analysts Forecast Growth

Several research firms recently commented on INGR. Oppenheimer raised their price objective on shares of Ingredion from $147.00 to $178.00 and gave the stock an "outperform" rating in a report on Wednesday, November 6th. BMO Capital Markets boosted their price objective on Ingredion from $128.00 to $147.00 and gave the company a "market perform" rating in a research note on Wednesday, November 6th. Barclays lifted their target price on Ingredion from $145.00 to $168.00 and gave the company an "overweight" rating in a report on Wednesday, November 6th. UBS Group increased their price target on shares of Ingredion from $165.00 to $173.00 and gave the stock a "buy" rating in a report on Friday, November 15th. Finally, Stephens raised shares of Ingredion to a "hold" rating in a research note on Monday, December 2nd. Two research analysts have rated the stock with a hold rating and five have issued a buy rating to the company's stock. According to MarketBeat.com, the stock presently has an average rating of "Moderate Buy" and an average target price of $155.17.

Read Our Latest Stock Analysis on INGR

Ingredion Profile

(Free Report)

Ingredion Incorporated, together with its subsidiaries, manufactures and sells sweeteners, starches, nutrition ingredients, and biomaterial solutions derived from wet milling and processing corn, and other starch-based materials to a range of industries in North America, South America, the Asia Pacific, Europe, the Middle East, and Africa.

Recommended Stories

Institutional Ownership by Quarter for Ingredion (NYSE:INGR)

Should you invest $1,000 in Ingredion right now?

Before you consider Ingredion, you'll want to hear this.

MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Ingredion wasn't on the list.

While Ingredion currently has a "Moderate Buy" rating among analysts, top-rated analysts believe these five stocks are better buys.

View The Five Stocks Here

Like this article? Share it with a colleague.

Featured Articles and Offers

Recent Videos

Broadcom Hits $1 Trillion – Can This AI Powerhouse Go Higher?
SoundHound Stock Explodes Again – Is a Major Breakout Coming?
How Fintech Strategy at FinWise Bancorp and CEO Vision Are Driving 78% Gains

Stock Lists

All Stock Lists

Investing Tools

Calendars and Tools

Search Headlines